Sonedenoson

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameSonedenoson
Drug Alias Name索奈迪松sonedenosonum索地诺生MRE-0094
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2a receptor agonists
TargetsAdenosine A2a receptor
Therapy Area/IndicationsDiabetes ComplicationsDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNew York University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsDiabetes ComplicationsDiabetic Foot

Other Information

ATC CodeN/A
Related LinksKEGG